小鼠药物相关性颌骨坏死发展过程中巨噬细胞极化研究
本研究在唑来膦酸处理并诱导实验性牙周病的小鼠中,观察药物相关性颌骨坏死(MRONJ)早期阶段巨噬细胞表型变化,并探索罗格列酮对MRONJ负担的影响。结果显示唑来膦酸组小鼠M1极化占优势,M1细胞表达MMP-13并与胶原网络破坏相关;罗格列酮逆转M1/M2极化,降低骨坏死百分比和骨暴露。
要点
- 唑来膦酸处理小鼠在MRONJ早期显示M1巨噬细胞极化占优势。
- M1细胞表达MMP-13,其出现与周围胶原网络破坏同时发生。
- 罗格列酮逆转M1/M2极化,减少唑来膦酸位点骨坏死和骨暴露。
核心结论
- M1巨噬细胞极化及MMP-13过表达在MRONJ早期发展中起重要作用。
- 促进M2表型的干预措施可能作为减轻MRONJ负担的预防手段。
研究设计与样本
- 小鼠接受唑来膦酸处理,并在左侧上颌第二磨牙周围诱导实验性牙周病。
- 小鼠在1、2或4周后处死,进行微计算机断层扫描、组织学和免疫组化分析。
- 另一实验中,小鼠接受唑来膦酸联合或不联合罗格列酮处理,诱导实验性牙周病5周后评估MRONJ负担。
主要发现
- 在结扎放置后1、2或4周,唑来膦酸组小鼠较载体组显示M1偏好。
- M1细胞呈MMP-13阳性,其存在与唑来膦酸小鼠周围胶原网络破坏同时发生。
- 罗格列酮导致载体组和唑来膦酸组小鼠M1/M2极化逆转。
- 实验性牙周病后5周,罗格列酮未引起载体组或唑来膦酸组动物显著影像学变化。
- 实验性牙周病后5周,罗格列酮处理的唑来膦酸位点较未处理位点骨坏死百分比和骨暴露降低。
临床怎么用
- 早期监测M1巨噬细胞极化和MMP-13表达可能有助于评估MRONJ风险。
- 促进M2表型的干预策略可能作为MRONJ的预防措施,但需进一步临床验证。
局限性
- 研究为小鼠模型,结论外推至人类需谨慎。
- 罗格列酮未引起显著影像学变化,其临床获益需进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Macrophages are important regulators of bone remodeling, and M1 polarization is observed in the setting of medication-related osteonecrosis of the jaws (MRONJ). Here, we characterize the phenotype of macrophages during early stages of MRONJ development in zoledronate (ZA)-treated mice with periodontal disease and explore the role of rosiglitazone, a drug that has been reported to lower the M1/M2 macrophage ratio, in MRONJ burden. Mice received ZA, and experimental periodontal disease (EPD) was induced around their second left maxillary molar. The mice were euthanized 1, 2, or 4 wk later. Micro-computed tomography and histologic and immunohistochemical analyses were carried out. In a separate experiment, mice were treated with ZA in the absence or presence of rosiglitazone, EPD was induced for 5 wk, and the MRONJ burden was assessed. An M1 predilection was noted in ZA versus vehicle (Veh) mice at 1, 2, or 4 wk after ligature placement. M1 cells were found to be positive for MMP-13, and their presence coincided with disruption of the surrounding collagen network in ZA mice. Rosiglitazone caused a reversal in the M1/M2 polarization in Veh and ZA mice. Rosiglitazone did not cause significant radiographic changes 5 wk after EPD in Veh or ZA animals. Importantly, percentage osteonecrosis and bone exposure were decreased in the rosiglitazone-treated versus nontreated ZA sites 5 wk after EPD. Our data point to an important role of M1 macrophage polarization with an overexpression of MMP-13 in the early phases of MRONJ development and provide insight into the use of interventional approaches promoting an M2 phenotype as a preventative means to alleviate MRONJ burden.
引用
- Soundia A, Elzakra N, Hadaya D, et al. Macrophage Polarization during MRONJ Development in Mice. J Dent Res. 2024. PMID: 39104155. doi:10.1177/00220345241258990
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。